Showing results (31-40 of 2,405) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|March 21, 2018
Prospective utility study of patients with multiple cardiovascular eventsRhys D Pockett, Phil McEwan, Joshua Ray, et al.Journal of Medical Economics|January 24, 2018
The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in JapanHitoshi Ishii, Matthew Madin-Warburton, Alena Strizek, et al.Journal of Medical Economics|January 12, 2018
Healthcare utilization and costs associated with treatment for opioid dependenceAnkit Shah, Margaret Duncan, Nipun Atreja, et al.Journal of Medical Economics|February 27, 2018
Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective studyAryana Sepassi, Francine Chingcuanco, Ronald Gordon, et al.Journal of Medical Economics|February 27, 2018
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of AmericaNoopur Raje, Garson David Roodman, Wolfgang Willenbacher, et al.Journal of Medical Economics|February 13, 2018
A best-worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatmentA Hendriks, B Wijnen, R van Engelen, et al.Journal of Medical Economics|December 23, 2017
Cost-effectiveness analysis of bariatric surgery for morbid obesity in BelgiumOleg Borisenko, Vasily Lukyanov, Isabelle Debergh, et al.Journal of Medical Economics|January 30, 2018
Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic frameworkMark P Connolly, Christine L Baker, Nikolaos KotsopoulosJournal of Medical Economics|October 11, 2017
Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab dataJoseph A Sierra, Mona Shah, Max S Gill, et al.Journal of Medical Economics|September 30, 2017
Cost-effectiveness analysis of telotristat ethyl for treatment of carcinoid syndrome diarrhea inadequately controlled with somatostatin analogsV N Joish, F Frech, P LapuertaPageof 241